XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
Total
CRMS
FMC NA
Healthwrox
Common Stock
Common Stock
CRMS
Common Stock
FMC NA
Additional Paid-in- Capital
Additional Paid-in- Capital
CRMS
Additional Paid-in- Capital
FMC NA
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
FMC NA
Accumulated Other Comprehensive Income
Noncontrolling Interests
Noncontrolling Interests
FMC NA
Noncontrolling Interests
Healthwrox
Beginning balance (in shares) at Dec. 31, 2022         102,411,162                      
Beginning balance at Dec. 31, 2022 $ 278,927,391       $ 10,241     $ 301,451,435     $ (28,972,216)   $ 741,206 $ 5,696,725    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of stock options (in shares)         96,101                      
Exercise of stock options 249,715       $ 10     249,705                
UK Ltd. restricted stock 167,175             167,175                
Stock-based compensation (in shares)         424,911                      
Stock-based compensation 8,181,591       $ 42     8,181,549                
Health liquidation 70,284                   70,284          
Net (loss) income attributable to noncontrolling interests (453,120)                         (453,120)    
Foreign currency translation 243,658                       243,658      
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries (3,465,670)                   (3,465,670)          
Ending balance (in shares) at Mar. 31, 2023         102,932,174                      
Ending balance at Mar. 31, 2023 283,921,024       $ 10,293     310,049,864     (32,367,602)   984,864 5,243,605    
Beginning balance (in shares) at Dec. 31, 2022         102,411,162                      
Beginning balance at Dec. 31, 2022 $ 278,927,391       $ 10,241     301,451,435     (28,972,216)   741,206 5,696,725    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock repurchased (in shares) 0                              
Net (loss) income attributable to noncontrolling interests $ 2,767,084                              
Foreign currency translation 66,965                              
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries (712,016)                              
Ending balance (in shares) at Sep. 30, 2023         103,874,539                      
Ending balance at Sep. 30, 2023 291,552,415       $ 10,387     315,745,338     (28,964,781)   808,171 3,953,300    
Beginning balance (in shares) at Mar. 31, 2023         102,932,174                      
Beginning balance at Mar. 31, 2023 283,921,024       $ 10,293     310,049,864     (32,367,602)   984,864 5,243,605    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of stock options (in shares)         260,410                      
Exercise of stock options 706,405       $ 26     706,379                
Stock-based compensation (in shares)         92,033                      
Stock based compensation, net of tax settled in shares 1,778,010       $ 9     1,778,001                
Acquisition of entities (in shares)           117,330 360,145                  
Acquisition of entities, amount   $ 1,000,012       $ 12 $ 36   $ 1,000,000 $ (1,432,963)   $ 649,167        
Purchase of interests     $ (3,997,716) $ (1,296,553)                     $ (3,213,956) $ (1,296,553)
Net (loss) income attributable to noncontrolling interests 3,354,886                         3,354,886    
Foreign currency translation 405,778                       405,778      
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries (2,011,267)                   (2,011,267)          
Ending balance (in shares) at Jun. 30, 2023         103,762,092                      
Ending balance at Jun. 30, 2023 283,860,579       $ 10,376     312,101,281     (33,729,702)   1,390,642 4,087,982    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of stock options (in shares)         88,837                      
Exercise of stock options 426,003       $ 8     425,995                
Cashless exercise of options ( in shares )         6,374                      
Cashless exercise of options $ 0       $ 1     (1)                
Common stock repurchased (in shares) 0                              
Stock-based compensation (in shares)         30,650                      
Stock-based compensation $ 3,335,710       $ 3     3,335,707                
Shares withheld for taxes (in shares)         (13,414)                      
Shares withheld for taxes (117,645)       $ (1)     (117,644)                
Net (loss) income attributable to noncontrolling interests (134,682)                         (134,682)    
Foreign currency translation (582,471)                       (582,471)      
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries 4,764,921                   4,764,921          
Ending balance (in shares) at Sep. 30, 2023         103,874,539                      
Ending balance at Sep. 30, 2023 $ 291,552,415       $ 10,387     315,745,338     (28,964,781)   808,171 3,953,300    
Beginning balance (in shares) at Dec. 31, 2023 104,055,168       104,055,168                      
Beginning balance at Dec. 31, 2023 $ 305,170,956       $ 10,406     320,693,866     (21,394,310)   1,484,905 4,376,089    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock repurchased (in shares)         (1,255,614)                      
Common stock repurchased (4,877,559)       $ (126)     (4,877,433)                
Stock-based compensation (in shares)         165,688                      
Stock-based compensation 4,340,405       $ 17     4,340,388                
Shares withheld for taxes (in shares)         (3,747)                      
Shares withheld for taxes (20,946)             (20,946)                
Net (loss) income attributable to noncontrolling interests (624,070)                         (624,070)    
Foreign currency translation (140,134)                       (140,134)      
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries 11,227,449                   11,227,449          
Ending balance (in shares) at Mar. 31, 2024         102,961,495                      
Ending balance at Mar. 31, 2024 $ 315,076,101       $ 10,297     320,135,875     (10,166,861)   1,344,771 3,752,019    
Beginning balance (in shares) at Dec. 31, 2023 104,055,168       104,055,168                      
Beginning balance at Dec. 31, 2023 $ 305,170,956       $ 10,406     320,693,866     (21,394,310)   1,484,905 4,376,089    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of stock options (in shares) 430                              
Net (loss) income attributable to noncontrolling interests $ (2,247,447)                              
Foreign currency translation 828,613                              
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries $ 23,254,953                              
Ending balance (in shares) at Sep. 30, 2024 101,980,995       101,980,995                      
Ending balance at Sep. 30, 2024 $ 324,903,537       $ 10,198     321,028,986     1,860,643   2,313,518 (309,808)    
Beginning balance (in shares) at Mar. 31, 2024         102,961,495                      
Beginning balance at Mar. 31, 2024 315,076,101       $ 10,297     320,135,875     (10,166,861)   1,344,771 3,752,019    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Exercise of stock options (in shares)         430                      
Exercise of stock options 684             684                
Common stock repurchased (in shares)         (1,395,957)                      
Common stock repurchased (4,904,452)       $ (140)     (4,904,312)                
Stock-based compensation (in shares)         181,136                      
Stock-based compensation 2,417,110       $ 18     2,417,092                
Shares withheld for taxes (in shares)         (64,334)                      
Shares withheld for taxes (245,386)       $ (7)     (245,379)                
Net (loss) income attributable to noncontrolling interests (671,029)                         (671,029)    
Dividends paid to noncontrolling interest (250,000)                         (250,000)    
Foreign currency translation 33,973                       33,973      
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries 6,529,603                   6,529,603          
Ending balance (in shares) at Jun. 30, 2024         101,682,770                      
Ending balance at Jun. 30, 2024 317,986,604       $ 10,168     317,403,960     (3,637,258)   1,378,744 2,830,990    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock repurchased (in shares)         (356,113)                      
Common stock repurchased (1,296,187)       $ (35)     (1,296,152)                
Stock-based compensation (in shares)         112,100                      
Stock-based compensation 2,874,427       $ 11     2,874,416                
Acquisition of entities, amount               340,450                
Purchase of interests (1,848,000)                         (2,188,450)    
Shares withheld for taxes (in shares)         (36,112)                      
Shares withheld for taxes (107,979)       $ (4)     (107,975)                
CRMS true-up payment (in shares)         578,350                      
CRMS True-up Payment 1,814,345       $ 58     1,814,287                
Net (loss) income attributable to noncontrolling interests (952,348)                         952,348    
Foreign currency translation 934,774                       934,774      
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries $ 5,497,901                   5,497,901          
Ending balance (in shares) at Sep. 30, 2024 101,980,995       101,980,995                      
Ending balance at Sep. 30, 2024 $ 324,903,537       $ 10,198     $ 321,028,986     $ 1,860,643   $ 2,313,518 $ (309,808)